CMR SURGICAL LIMITED
Get an alert when CMR SURGICAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-01-17 (in 8mo)
Last made up 2026-01-03
Watchouts
None on the register
Cash
£28M
-75.5% vs 2023
Net assets
£153M
-45.4% vs 2023
Employees
633
-22.9% vs 2023
Profit before tax
-£131M
+2.5% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £52,854,000 | £38,146,000 | |
| Operating profit | -£135,086,000 | -£132,049,000 | |
| Profit before tax | -£133,981,000 | -£130,568,000 | |
| Net profit | -£133,177,000 | -£131,501,000 | |
| Cash | £116,137,000 | £28,490,000 | |
| Total assets less current liabilities | £299,079,000 | £168,566,000 | |
| Net assets | £279,448,000 | £152,561,000 | |
| Equity | £279,448,000 | £152,561,000 | |
| Average employees | 821 | 633 | |
| Wages | £55,308,000 | £41,816,000 | |
| Directors' remuneration | £963,000 | £697,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-27.8%
£52,854,000 £38,146,000
-
Cash
-75.5%
£116,137,000 £28,490,000
-
Net assets
-45.4%
£279,448,000 £152,561,000
-
Employees
-22.9%
821 633
-
Operating profit
+2.2%
-£135,086,000 -£132,049,000
-
Profit before tax
+2.5%
-£133,981,000 -£130,568,000
-
Wages
-24.4%
£55,308,000 £41,816,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | -45.2% | -78.3% | |
| Gearing (liabilities / total assets) | 18.0% | 24.7% | |
| Current ratio | 6.79x | 4.60x | |
| Interest cover | -94.27x | -86.42x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- CMR SURGICAL LIMITED 2018-02-26 → present
- CAMBRIDGE MEDICAL ROBOTICS LIMITED 2014-01-27 → 2018-02-26
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Consolidated group
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis. ... The directors have therefore prepared a reasonable downside case, which shows that the Group still has sufficient liquid resources available to meet its liabilities as and when they fall due during the period.”
Group structure
- CMR SURGICAL LIMITED · parent
- CMR Surgical Inc 100%
- CMR Surgical Srl 100%
- CMR Surgical Spain SL 100%
- CMR Surgical GmbH 100%
- CMR Surgical SAS 100%
- CMR Surgical India Private Ltd 100%
- CMR Surgical FZCO 100%
- CMR Surgical Chile SpA 100%
- CMR Surgical Device Co Ltd 77%
- CMR Surgical Brasil Importacio e Comercio de Equipamentos Medicos Ltda 100%
- CMR Surgical AB 100%
- Cambridge Medical Robotics Limited 100%
Significant events
- “In October 2024, the Group secured a significant regulatory approval, receiving US FDA De Novo Authorisation for the use of Versius® in cholecystectomy procedures in adults.”
- “The Group obtained CE Mark Approval for the Ultrasonic Dissector, a new addition to the Versius Plus portfolio designed to enhance surgical precision and efficiency by delivering ultrasonic energy for precise cutting and coagulation of tissue.”
- “The Group closed a new fundraising round of £163.5m to support the Group's continued growth and commercial development. Including the receipt of £107m, as of 25 March 2025, the Group had cash reserves of £124m.”
- “The Company obtained further funding from convertible loan notes in Q1 2025 totalling £108.5m.”
- “The Company also obtained a debt facility in Q1 2025 for a further £55m.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
9 active · 22 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2023-07-12 | — | — |
| BOSE, Supratim | Director | 2023-06-15 | Aug 1952 | Singaporean |
| CASSIDY, John | Director | 2022-10-27 | Jul 1988 | British |
| COLELLA, Massimiliano | Director | 2025-01-02 | Jul 1968 | Italian |
| HURSEVER, Sakip-Umur, Mr. | Director | 2018-05-10 | Apr 1975 | German,Turkish |
| MOORE, Daniel Jeffrey | Director | 2024-07-15 | Mar 1961 | American |
| MOUKHEIBIR, Catherine | Director | 2021-01-01 | Nov 1959 | Lebanese |
| MTIBELISHVILI, Irackli | Director | 2022-10-11 | Oct 1971 | Georgian |
| PLACHTYNA, Steven | Director | 2024-11-05 | Jul 1990 | American |
Show 22 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DAY, Simon Christopher | Secretary | 2017-02-07 | 2023-07-21 |
| CHRISTOU, Victor, Dr | Director | 2018-10-03 | 2019-04-23 |
| FARHAT, Camille | Director | 2019-04-26 | 2021-02-23 |
| FROST, Martin John | Director | 2014-01-27 | 2020-12-31 |
| INDAHL, Reynir | Director | 2015-10-22 | 2018-05-10 |
| KULKOV, Egor | Director | 2016-07-15 | 2022-10-11 |
| LANGAKER, Erik | Director | 2016-07-15 | 2019-12-31 |
| LONDY, Kelly | Director | 2019-01-29 | 2024-02-29 |
| MARSHALL, Keith | Director | 2020-01-01 | 2020-06-30 |
| MCCOMB, William | Director | 2020-09-18 | 2023-03-30 |
| METHI, Per Christian | Director | 2014-01-28 | 2024-05-01 |
| MUZZI, Massimo | Director | 2016-07-15 | 2018-04-23 |
| NERSETH, Per Vegard | Director | 2020-01-01 | 2023-03-27 |
| OIE, Ingeborg Dybdal | Director | 2019-03-26 | 2021-06-28 |
| RANDLE, Steven James | Director | 2014-02-01 | 2015-07-31 |
| SLACK, Mark | Director | 2020-06-30 | 2021-06-28 |
| SLACK, Mark | Director | 2014-02-01 | 2018-04-23 |
| TANSLEY, Robert Giles, Dr | Director | 2019-04-23 | 2019-09-11 |
| TANSLEY, Robert Giles, Dr | Director | 2016-07-15 | 2018-10-03 |
| VERNON, Anthony | Director | 2020-09-01 | 2023-03-29 |
| WELLS, Elizabeth Alice | Director | 2021-08-19 | 2022-10-27 |
| YU, Fan, Mr. | Director | 2023-08-15 | 2024-11-05 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Egor Kulkov | Individual | Shares 25–50%, Voting 25–50% | 2016-04-06 | Ceased 2022-12-20 |
| Escala Capital Investments Cyprus Limited | Corporate entity | ownership-of-shares-50-to-75-percent-as-firm, voting-rights-50-to-75-percent-as-firm, right-to-appoint-and-remove-directors-as-firm | 2016-04-06 | Ceased 2016-04-06 |
Filing timeline
Last 20 of 190 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-04-03 RESOLUTIONS Resolution
- 2025-02-18 RESOLUTIONS Resolution
- 2025-02-18 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-21 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-01-16 | SH01 | capital | Capital allotment shares | |
| 2025-07-09 | SH01 | capital | Capital allotment shares | |
| 2025-05-19 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-05-02 | SH01 | capital | Capital allotment shares | |
| 2025-04-14 | AA | accounts | Accounts with accounts type group | |
| 2025-04-03 | RESOLUTIONS | resolution | Resolution | |
| 2025-04-03 | SH01 | capital | Capital allotment shares | |
| 2025-04-01 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-03-28 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-03-28 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-03-28 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-03-26 | SH01 | capital | Capital allotment shares | |
| 2025-03-04 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-03-03 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-02-27 | AP01 | officers | Appoint person director company with name date | |
| 2025-02-18 | RESOLUTIONS | resolution | Resolution | |
| 2025-02-18 | MA | incorporation | Memorandum articles | |
| 2025-01-29 | AP01 | officers | Appoint person director company with name date | |
| 2025-01-17 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 5
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.